Abstract: Variable-capacity store for cylindrical articles of the tobacco processing industry; the store comprises a conveying assembly comprising a first conveyor having a substantially helical shape; a second conveyor having a substantially helical shape and arranged above the first conveyor; and a linear transfer conveyor, which is adapted to convey the articles from the first conveyor to the second conveyor, having a variable length and, by extending and shortening, changes the area of the first conveyor from which it picks up the articles and the area of the second conveyor to which it feeds the articles, thus varying the capacity of the store.

Abstract: The invention relates to a support mount (10) for a wiper blade, the mount (10) comprising a body having a main longitudinal extension direction, known as the main direction (X), the body comprising a first means for receiving a bending length and second means defining a lower housing (20), open, to hold an upper mounting stub for a wiper blade of the wiper, characterised in that the first means defines an upper housing (30) designed so as to cover the length along the main direction (X) and in that the upper housing (30) comprises a plurality of recesses (32, 32?, 32?) facilitating the bending of the mount (10), the recesses forming a pattern (M1-M10) on the surface of the upper housing (30), known as the recess distribution pattern (M1-M10). The invention also relates to a wiper blade comprising a mount (10) and a wiping system comprising such a wiper.

Abstract: There is provided a method and system for digital rights enforcement. The method includes: determining digital content requested by a user via a selected user device; determining digital rights associated with the digital content; reviewing the digital rights to determine access rights relating to authorized devices for the user; determining whether the user has exhausted the access rights; and if the access rights are exhausted: determining at least one use factor for each of the user's previously authorized user devices; determining a previously authorized user device on which to revoke access to the digital content based on the at least one use factor; and revoking access rights to the previously authorized user associated device; otherwise downloading the digital content on the selected user device. The system includes a content review module and a revoker module.

Abstract: A system and method for producing fine droplets of polysaccharide from a premixed water-in-oil emulsion uses a packed bed (5) comprising hydrophilic beads (7).

Abstract: A composition of AR layer that is aimed to match the refractive index of the underlying substrate e.g. glass, chemically strengthened glass, plastics etc., so as maximum light is transmitting through it. For a device with an sapphire film for anti-scratch protection, because sapphire has a different refractive index to that of the substrate, therefore existing AR layer will not function as well as it should; not only the transmitted light is reduced in quantity, its transmitted range will be changed such that imaging or display color is compromised. Therefore an integrated AR with sapphire film with the top most AR layer as Al2O3 which also acts as anti-scratching layer will eliminate this problem. This claim involves replacing one of the materials for AR layer is Al2O3 such that the top most AR layer as Al2O3 which also acts as anti-scratching layer.

Abstract: Methods and systems are for determining the concentration of a chemical species in an analyte solution. At least one train of segments are injected into a microfluidic channel having a first end and a second end, each train of segments having segments of analyte solution and segments of sensing solution which are immiscible with the segments of analyte solution. The train of segments is circulated from the first end to the second end of the microfluidic channel such that a reversible chemical exchange is established between the chemical species of each segment of analyte solution and a chemical indicator of the at least one contacting segment of sensing solution. The response of the chemical indicator is measured at the second end of the microfluidic channel and the concentration of the chemical species in the analyte solution is determined based on the response.

Abstract: Compounds of formula (I) are A2B receptor antagonists: Wherein R1 is optionally substituted aryl or an optionally substituted 5- or 6-membered heteroaryl ring; R2 and R3 are independently selected from hydrogen, C1-C6 alkyl, C3-C8 cycloalkyl, C3-C8 cycloalkyl-(C1-C6)-alkyl, aryl-(C1-C6)-alkyl optionally substituted in the ring part thereof, a 5- or 6-membered monocyclic heterocyclic group optionally linked via a C1-C6 alkylene chain and optionally substituted in the ring part thereof, benzimidazol-2-yl-methyl, pyrid-3-yl-carbonyl, or (1-methyl-piperidin-4-yl)-carbonyl-methyl; or R2 and R3 taken together with the nitrogen atom to which they are attached form an optionally substituted 5- or 6-membered ring; R4 is C1-C3 alkyl, C2-C3 alkenyl, —N(—R5)—R6, or optionally substituted heteroarylmethylamino; and R5 and R6 are independently selected from hydrogen or C1-C3 alkyl; or R5 and R6 taken together with the nitrogen atom to which they are attached form an optionally substituted 4- to 6-membered saturated rin

Abstract: A method device, and system is described herein for pushing a rotary drill bit. Pushing the rotary drill bit ears include receiving a target direction in a formation to push the rotary drill bit wile drilling a wellbore in a formation. Pushing the rotary drill bit can also include opening, at a first rotational position of a rotary bit pushing device disposed proximate to the rotary drill bit within the wellborn, a first inlet port of a first flow regulator. Pushing the rotary drill bit can further include closing, after the first rotational position of the rotary bit pushing device the first inlet port. Pushing the rotary drill bit can also include sending, to a second flow regulator of the rotary bit pushing device, a second quantity of drilling fluid.

Abstract: The present invention concerns a key (1) for locking a link including a U-section and a crank of a linkage of a wiper mechanism in a transport position, characterized in that it comprises: a shaft (11) having at one end a radial holding excrescence (13) and at the other end an enlarged head (15) intended to cooperate with a hollow part of the U-section forming the link, and a first radial finger (17) configured to be housed in a slot for locking the link in the transport position.

Abstract: A polyethylene terephthalate (PET) polymer having diacid units derived from diacid compounds, said diacid units comprising: a) from 92.50 mol % to 97.75 mol % of terephthalic units derived from terephthalic acid (TA) or an ester thereof, and b) from 2.25 mol % to 7.50 mol % of 2,5-FDCA units derived from 2,5- furandicarboxylic acid (2,5-FDCA) or an ester thereof, and-diol units derived from diol compound(s), the diol units having monoethylene glycol units derived from monoethylene glycol (MEG), as well as to a method to prepare a PET polymer. The use of a 2,5-FDCA compound selected from 2,5- furandicarboxylic acid (2,5-FDCA) and esters thereof as an anti-crystallization comonomer in a PET polymer and a bio-based PET polymer in which the anti-crystallisation comonomer is bio-based.

Abstract: Apparatus and methods enable active compensation for unwanted discrepancies in the superconducting elements of a quantum processor. A qubit may include a primary compound Josephson junction (CJJ) structure, which may include at least a first secondary CJJ structure to enable compensation for Josephson junction asymmetry in the primary CJJ structure. A qubit may include a series LC-circuit coupled in parallel with a first CJJ structure to provide a tunable capacitance. A qubit control system may include means for tuning inductance of a qubit loop, for instance a tunable coupler inductively coupled to the qubit loop and controlled by a programming interface, or a CJJ structure coupled in series with the qubit loop and controlled by a programming interface.

Abstract: In the present invention, compound such as (1R,2S)-2-(((2,4-dimethylpyrimidin-5-yl)oxy)methyl)-2-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl) cyclopropanecarboxamide have been found to be potent orexin receptor antagonists, and may be useful in the treatment of sleep disorders such as insomnia, as well as for other therapeutic uses.

Abstract: In a wireless communication system, SINR data are obtained from power measurements data, as follows: gathering first power measurements data of total power received during communications; gathering second power measurements data of in-transmission interference power; computing third power measurements data of useful power, from the first and second power measurements data; gathering fourth power measurements data of out-transmission interference power; merging the second and fourth power measurements data so as to form a set of fifth interference power data; computing a first characteristic function from the third power measurements data, and computing a second characteristic function from the fifth power measurements data; building a third characteristic function relating to the SINR data related to the transmission channel, by performing a term-by-term product of the first and second characteristic functions; computing a probability mass function from the third characteristic function.

Abstract: Compound of formula (I): wherein Het, R3, R4, R5, R7, R8, R9, t, p, p?, q, and q? are as defined in the description. Medicinal products containing the same which are useful in treating conditions requiring pro-apoptotic agent.

Abstract: The present invention relates to an improved process for the preparation of (2S)-2-[(4R)-2-oxo-4-propyltetrahydro-1H-pyrrol-1-yl] butanamide compound of formula-1, its intermediates, novel salt compounds of intermediates of the compound of formula-1. Further the use of novel salts in the preparation of the compound of formula-1. The present invention also relates to the novel process for the preparation of the compound of formula-1.

Abstract: The present disclosure provides novel pladienolide compounds, pharmaceutical compositions containing such compounds, and methods for using the compounds as therapeutic agents. These compounds may be useful in the treatment of cancers, particularly cancers in which agents that target the spliceosome and mutations therein are known to be useful. Also provided herein are methods of treating cancers by administering at least one compound disclosed herein and at least one additional therapy.

Abstract: The invention relates to method of enhancing yield of alkyl taurate amides using enhancing specifically phosphoric acid catalysts. It further relates to the use of phosphoric acid to enhance yield while avoiding and/or reducing undesirable browning.

Abstract: The invention relates to a drive arm for driving a wiper blade intended for a motor vehicle, the drive arm extending in a longitudinal direction (X), the drive arm comprising at least one first attachment means (224) for a first end of an elastic return device and at least one second attachment means (234) for the first end of the elastic return device, characterized in that a first distance (d1) measured parallel to the longitudinal direction (X) between the first attachment means (224) and the second attachment means (234) is not zero.

Abstract: The present invention relates to an aqueous extract useful notably for the regeneration of human or animal cells, notably mammalian cells, comprising an aqueous extract free of any insoluble solid debris of ground planarian organisms having a regeneration capacity, containing at least the intracellular components of the cells of said organisms of a cell lysate of said cells of said organisms.

Abstract: The invention provides a solid composition of the peripheral mu opioid antagonist axelopran and a combination dosage form of the mu opioid antagonist axelopran sulfate in an immediate release form and an opioid analgesic agent which may be in an extended release, sustained release, modified release, or controlled release form and methods of preparing such a combination dosage form.